FDA Approves Unknown Drug — RHODES PHARMS
Rhodes Pharmaceuticals' FDA approval of ANDA205853 facilitates the entry of a generic alternative, a maneuver expected to broaden the company's revenue base and reinforce its competitive standing in the sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day